The largest database of trusted experimental protocols

Macconkey agar

Manufactured by Biolife
Sourced in Italy

MacConkey agar is a selective and differential culture medium used for the isolation and identification of Gram-negative enteric bacteria, particularly members of the Enterobacteriaceae family. It contains bile salts and crystal violet, which inhibit the growth of Gram-positive bacteria, while allowing the growth of Gram-negative bacteria. The medium also includes lactose, and the fermentation of this carbohydrate by lactose-fermenting bacteria results in the production of acidic byproducts, which are detected by the pH indicator neutral red.

Automatically generated - may contain errors

7 protocols using macconkey agar

1

Bacterial Isolate Identification and Storage

Check if the same lab product or an alternative is used in the 5 most similar protocols
Clinical specimens were cultured aseptically onto blood agar (Columbia agar with 5% Sheep blood, 254005 BD), chocolate agar (GC II agar with IsoVitaleX, 254060, BD, Franklin Lakes NJ, USA)) and MacConkey agar (4016702, Biolife Italiana Srl, Milano, Italy) and incubated at 35–37 °C in aerobic conditions with 5–10% CO2 for 24–48 hours. Identification of isolates (APP, PM, BB and GP) was carried out by matrix-assisted laser desorption ionization-time of flight (MALDI-TOF Biotyper System, Bruker Daltonics, Bremen, Germany). Individual strains were stored at −80 °C in brain heart infusion (CM1135, Oxoid, Madrid, Spain) with 30% of glycerol (G9012, Sigma-Aldrich, Madrid, Spain).
+ Open protocol
+ Expand
2

Microbial Analysis of Vermicompost

Check if the same lab product or an alternative is used in the 5 most similar protocols
The beds of BSG, CM and BSG/CM and the resulting vermicomposts (after 5 months with the earthworms) were analysed according to Grantina-Ievina et al. (2013) . The total number of bacteria was estimated after 24 h incubation on nutrient agar medium (Biolife Italiana S.r.l., Milan, Italy) with 0.01% cycloheximide. The Lactobacilli were estimated after 24 h incubation on Man, Rogosa and Sharpe agar (Biolife Italiana S.r.l., Milan, Italy) with 0.01% cycloheximide, at 30 ±2 °C. The total numbers of cultivable filamentous fungi and yeast were estimated after 48 h incubation on potato destrose agar (Biolife Italiana S.r.l., Milan, Italy) with 0.1% chloramphenicol, at 24 ±2 °C. The numbers of E. coli and coliforms were estimated after 48 h incubation on Mac Conkey agar (Biolife, Milan, Italy), at 37 ±2 °C. These data are expressed as colony forming units (CFU) × dilution factor × sample weight (g -¹). Three replicates were performed for each sample.
For detection of Salmonella spp., 25g samples were enriched in peptone water for 1 day at 37 ±2 °C, followed by isolation on Salmonella-Shigella agar (Bio-Rad, Hercules, CA, USA), at 37 ±2 °C for 1 day.
+ Open protocol
+ Expand
3

Antibiotic Resistance Profiling of Clinical Isolates

Check if the same lab product or an alternative is used in the 5 most similar protocols
The bacteria were recent clinical isolates, belonging to the Institute of Microbiology (University of Genova) collection. They comprised of: (i) ten S. aureus strains, including five methicillin-resistant (MRSA) and five methicillin-susceptible (MSSA) strains. Of the MRSA strains, three were multi-resistant (resistant to at least three classes of antibiotics); (ii) ten multi-resistant Escherichia coli strains; (iii) ten Pseudomonas aeruginosa strains; (iv) ten vancomycin-resistant and susceptible Enterococcus faecalis and Enterococcus faecium strains; and (v) ten group A streptococci (Streptococcus pyogenes) strains, which remain universally susceptible to penicillin. All isolates were identified at the species level using clinical methods and an API STAPH, API20E, API NE and API STREP system (bioMèrieux, Marcy l’Etoile, France) for S. aureus, E. coli, P. aeruginosa, Enterococcus spp. and S. pyogenes respectively. The antibiotype was determined using the disk diffusion test, as according to the latest Clinical and Laboratory Standards Institute (CLSI) guidelines [57 ]. Strains were cultured in Mueller-Hinton Broth, Mueller-Hinton agar, MacConkey agar and Columbia blood agar (Biolife, Milan, Italy) at 37 °C.
+ Open protocol
+ Expand
4

Isolation and Identification of Causative Organism

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following culture media were used for isolation, identification and viable count of the causative organism.
Blood Agar (Oxoid).
Blood Agar Base (Oxoid) (pH 7.2).
Cystine Lactose Electrolyte Deficient(Oxoid) • DNASE Agar Mast (Oxoid) pH 7.3.
Mac Conkey Agar No. 3 (Oxoid) pH7.1.
MacConkey Agar (Pronadisa).
Mannitol Salt Agar (LAMB).
Muller Hinton Agar (Biolife).
• Muller Hinton Broth (LABM) pH 7.4 ± 0.2.
• Nutrient Agar (Pronadisa) pH 6.8.
+ Open protocol
+ Expand
5

Isolation and Identification of Respiratory Pathogens

Check if the same lab product or an alternative is used in the 5 most similar protocols
Clinical specimens were cultured aseptically onto blood agar (Columbia agar with 5% Sheep blood, 254,005 BD), chocolate agar (GC II agar with IsoVitaleX, 254,060, BD or blood Agar No. 2 Base, 257,011, BD) and MacConkey agar (4,016,702, Biolife Italiana Srl) and incubated at 35–37 °C in aerobic conditions with 5–10% CO2 for 24–48 h to address the isolation of respiratory bacterial pathogens.
Identification of isolates for respiratory pathogens was carried out by matrix assisted laser desorption ionization-time of flight (MALDI-TOF Biotyper System, Bruker Daltonics, Bremen, Germany) as previously described [13 (link)]. Actinobacillus pleuropneumoniae was also confirmed by PCR technique due to limitation of MALDI-TOF for the Actinobacillus genus [57 (link)]. Individual isolates were stored at -80 °C in brain heart infusion (CM1135, Oxoid) with 30% of glycerol (G9012, Sigma-Aldrich).
+ Open protocol
+ Expand
6

Multidrug-Resistant Klebsiella pneumoniae Collection

Check if the same lab product or an alternative is used in the 5 most similar protocols
One hundred and two K. pneumoniae isolates with an MDR profile were provided by the microbiology laboratories of the Hospital de Braga and of the Centro Hospitalar De Trás Os-Montes E Alto Douro, E.P.E., both in northern Portugal. Isolates were collected over a period of ten years (2010–2020). This study was performed in line with the principles of the Declaration of Helsinki and the guidelines of Good Clinical Practice. Approval was granted by the Ethics Committee of Life and Health Sciences Research Institute (ICVS), School of Health Sciences, University of Minho, Braga, Portugal. The isolates provided were previously identified using VITEK®2 Compact B System (bioMérieux, Marcy-l’Étoile, France). Even so, the bacterial isolates were cultured on MacConkey agar (BioLife, Milan, Italy) plates, and typical K. pneumoniae colonies were sub-cultured onto trypticase soy agar (TSA, Liofilchem, Roseto degli Abruzzi, Italy) for further analysis. Isolates were also preserved in 20% (v/v) glycerol (Riedel-de-Haën, Seelze, Germany) in tryptic soy broth (TSB, Liofilchem) and stored at −80 °C. The sample sources and isolation dates from all isolates were gathered together with the bacterial species information.
+ Open protocol
+ Expand
7

Identification of Bacterial Isolates

Check if the same lab product or an alternative is used in the 5 most similar protocols
Clinical specimens were grown aseptically on Columbia blood agar base supplemented with 5% of defibrinated sheep blood (Oxoid), chocolate blood agar (GC II agar with IsoVitaleX, BD) and MacConkey agar (Biolife). All plates were incubated at 35–37 °C in aerobic conditions with 5–10% CO2 for 24–48 h. Identification of isolates was carried out by matrix assisted laser desorption ionization-time of flight (MALDI-TOF) mass espectrometry (Biotyper System, Bruker Daltonics, Bremen, Germany) as previously described [24 (link)].
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!